陈 梅,钟 颖,明建中.miRNA-145在卵巢癌组织中的表达及其对增殖、迁移与侵袭的影响[J].肿瘤学杂志,2019,25(7):607-611.
miRNA-145在卵巢癌组织中的表达及其对增殖、迁移与侵袭的影响
Expression of miRNA-145 in Ovarian Cancer and Its Effect on Proliferation,Migration and Invasion
投稿时间:2018-07-05  
DOI:10.11735/j.issn.1671-170X.2019.07.B004
中文关键词:  miRNA-145  卵巢癌  细胞增殖  细胞迁移  细胞侵袭
英文关键词:miRNA-145  ovarian cancer  cell proliferation  cell migration  cell invasion
基金项目:
作者单位
陈 梅 南方科技大学医院 
钟 颖 南方科技大学医院 
明建中 广东医学院附属深圳南山医院 
摘要点击次数: 1435
全文下载次数: 304
中文摘要:
      摘 要:[目的] 检测不同卵巢组织中miRNA-145的表达,并探讨miRNA-145在卵巢细胞SKOV-3增殖、迁移与侵袭的作用。[方法] 采用定量聚合酶链反应(qPCR)测定正常卵巢组织、卵巢癌旁组织与卵巢癌卵巢组织的miRNA-145表达水平,随机将SKOV-3细胞分为正常对照组、空白病毒组和病毒转染组,分别采用MTT法测定各组细胞的增殖情况,采用qPCR测定miRNA-145的表达水平,采用划痕实验测定迁移能力,采用Transwell小室法测定侵袭能力。[结果] 卵巢癌组织miRNA-145表达水平为0.56±0.23,较卵巢癌旁组织和正常卵巢组织显著性降低(P<0.05)。卵巢癌组织miRNA-145表达水平与患者国际妇产科联合会分期和组织分化程度相关(P<0.05),但与年龄无关(P >0.05)。病毒转染组细胞的miRNA-145表达水平为4.63±0.47,较正常对照组和空白病毒对照组显著性增加(P<0.05)。病毒转染组细胞在培养24h、48h和72h时OD值分别为0.68±0.15、1.17±0.23和1.62±0.26,均较正常对照组和空白病毒对照组显著性降低(P<0.05)。病毒转染组细胞的划痕宽度为675±46μm,较正常对照组和空白病毒对照组显著性增大(P<0.05)。病毒转染组穿膜细胞数量为36±6个,较正常对照组和空白病毒对照组显著性降低(P<0.05)。[结论] miRNA-145低表达可能与卵巢癌的发生发展有关,过表达miRNA-145能够抑制卵巢癌细胞株的增殖、迁移和侵袭。miRNA-145可以作为治疗卵巢癌的新作用靶点。
英文摘要:
      Abstract:[Objective] To investigate the expression of miRNA-145 in ovarian carcinoma and its effect on cell proliferation,migration and invasion. [Methods] Expression of miRNA-145 in normal ovarian tissue,the tissue adjacent to ovarian cancer and ovarian cancer was determined by qRT-PCR. Human ovarian cancer SKOV-3 cells were transfected with miRNA-145-mimic(miRNA-145 group) or blank viral vector(miRNA-145-NC group),and the untransfected SKOV-3 cells served as control group. Cell proliferation was determined by MTT method,expression of miRNA-145 were determined by qRT-PCR,cell migration was determined by scratch experiment,and cell invasion was determined by Transwell small chamber method.[Results] The expression level of miRNA-145 in ovarian cancer tissue was 0.56±0.23,which was significantly lower than that in pericancerous ovarian tissue and normal ovarian tissue(P<0.05). The miRNA-145 expression level in ovarian cancer tissue was correlated with FIGO stages and differentiation degrees(P<0.05),but not correlated with the age of patients(P>0.05). Expression level of miRNA- 145 in miRNA-145 group was 4.63±0.47,which was significantly higher than that in normal control group and miRNA-145-NC group(P<0.05). OD values in miRNA-145 group after incubation for 24h,48h and 72h were 0.68±0.15,1.17±0.23 and 1.62±0.26,which were significantly lower than those in normal control group and miRNA-145-NC group after incubation for 24h,48h and 72h(P<0.05). Scratch width of cells in miRNA-145 group was 675±46μm,which was significantly larger than that in normal control group and miRNA-145-NC group(P<0.05). Quantity of transfected cells in miRNA-145 group was 36±6,which was significantly lower than that in normal control group and miRNA-145-NC group(P<0.05). [Conclusion] Decreased expression of miRNA-145 may be associated with occurrence and development of ovarian cancer,over-expression of miRNA-145 can inhibit the proliferation,migration and invasion of ovarian cancer cells. miRNA-145 might be used as a new target for treatment of ovarian cancer.
在线阅读   查看全文  查看/发表评论  下载PDF阅读器